APT Medical Inc. (SHA:688617)

APT Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	1,276	250.88	309.66	120.34
Trading Asset Securities	-	60	881.34	913.72	-
Cash & Short-Term Investments	960.58	1,336	1,132	1,223	120.34
Cash Growth	-28.12%	18.03%	-7.45%	916.56%	63.69%
Accounts Receivable	-	41.78	47.15	34.01	43.72
Other Receivables	-	8.76	14.14	13.45	5.97
Receivables	-	50.54	61.29	47.46	49.69
Inventory	-	327.95	337.94	263.25	145.27
Other Current Assets	-	41.18	26.01	19.15	34.96
Total Current Assets	-	1,756	1,557	1,553	350.26
Property, Plant & Equipment	-	464.46	319.93	258.73	155.11
Long-Term Investments	-	159.8	178.17	121.27	32.81
Goodwill	-	48.13	-	-	-
Other Intangible Assets	-	83	38.92	32.38	32.47
Long-Term Deferred Tax Assets	-	10.73	12.64	9.82	1.62
Long-Term Deferred Charges	-	5.95	5.09	7.41	1.62
Other Long-Term Assets	-	44.83	113.77	30.24	14.82
Total Assets	-	2,573	2,226	2,013	588.71
Accounts Payable	-	29.56	34.65	18	8.19
Accrued Expenses	-	161.28	119.18	94.68	62.14
Short-Term Debt	-	70	30	16	10.5
Current Portion of Long-Term Debt	-	1.18	7.27	6.09	5
Current Portion of Leases	-	10.1	6.26	7.46	-
Current Income Taxes Payable	-	19.86	13.3	9.35	3.38
Current Unearned Revenue	-	44.4	38.65	32.32	16.71
Other Current Liabilities	-	251.79	162.57	10.63	3.5
Total Current Liabilities	-	588.17	411.88	194.53	109.41
Long-Term Debt	-	0.59	1.77	10.23	23.59
Long-Term Leases	-	7.99	7.29	6.8	-
Long-Term Unearned Revenue	-	8.74	7.06	7.3	5.62
Long-Term Deferred Tax Liabilities	-	5.49	6.92	3.16	-
Total Liabilities	-	610.98	434.91	222.02	138.62
Common Stock	-	66.86	66.67	66.67	50
Additional Paid-In Capital	-	724.04	1,013	1,268	159.47
Retained Earnings	-	1,141	716.83	425.49	250.9
Treasury Stock	-	-59.99	-59.99	-	-
Comprehensive Income & Other	-	34.96	27.22	17.89	-0.01
Total Common Equity	2,388	1,907	1,763	1,778	460.36
Minority Interest	-	54.86	27.75	12.95	-10.27
Shareholders' Equity	2,436	1,962	1,791	1,791	450.09
Total Liabilities & Equity	-	2,573	2,226	2,013	588.71
Total Debt	12.44	89.86	52.59	46.58	39.09
Net Cash (Debt)	948.14	1,247	1,080	1,177	81.25
Net Cash Growth	-23.94%	15.46%	-8.26%	1348.33%	-
Net Cash Per Share	9.80	12.75	11.02	12.37	1.12
Filing Date Shares Outstanding	95.8	96.5	96.22	96.67	72.5
Total Common Shares Outstanding	96.88	96.5	96.67	96.67	72.5
Working Capital	-	1,168	1,146	1,359	240.85
Book Value Per Share	24.65	19.76	18.24	18.39	6.35
Tangible Book Value	1,940	1,776	1,724	1,746	427.89
Tangible Book Value Per Share	20.02	18.40	17.84	18.06	5.90
Buildings	-	173.2	150.44	81.94	69.27
Machinery	-	402.93	277.15	223.7	141.71
Construction In Progress	-	47.84	14.99	37.31	17.64

Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.